NO20006149L - Oksazolidinonderivater, fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger som inneholder dem - Google Patents

Oksazolidinonderivater, fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger som inneholder dem

Info

Publication number
NO20006149L
NO20006149L NO20006149A NO20006149A NO20006149L NO 20006149 L NO20006149 L NO 20006149L NO 20006149 A NO20006149 A NO 20006149A NO 20006149 A NO20006149 A NO 20006149A NO 20006149 L NO20006149 L NO 20006149L
Authority
NO
Norway
Prior art keywords
preparation
methods
pharmaceutical compositions
compositions containing
oxazolidinone derivatives
Prior art date
Application number
NO20006149A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006149D0 (no
Inventor
Michael Barry Gravestock
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20006149D0 publication Critical patent/NO20006149D0/no
Publication of NO20006149L publication Critical patent/NO20006149L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20006149A 1998-06-05 2000-12-04 Oksazolidinonderivater, fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger som inneholder dem NO20006149L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9812019.9A GB9812019D0 (en) 1998-06-05 1998-06-05 Chemical compounds
PCT/GB1999/001737 WO1999064416A2 (fr) 1998-06-05 1999-06-03 Derives d'oxazolidinone, leur procede de preparation et compositions pharmaceutiques contenant ceux-ci

Publications (2)

Publication Number Publication Date
NO20006149D0 NO20006149D0 (no) 2000-12-04
NO20006149L true NO20006149L (no) 2001-02-02

Family

ID=10833201

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006149A NO20006149L (no) 1998-06-05 2000-12-04 Oksazolidinonderivater, fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger som inneholder dem

Country Status (16)

Country Link
EP (2) EP1357122A3 (fr)
JP (1) JP2002517497A (fr)
KR (1) KR20010052590A (fr)
CN (1) CN1304410A (fr)
AT (1) ATE258552T1 (fr)
AU (1) AU753865B2 (fr)
BR (1) BR9910915A (fr)
CA (1) CA2332831A1 (fr)
DE (1) DE69914478T2 (fr)
GB (1) GB9812019D0 (fr)
HU (1) HUP0103404A3 (fr)
IL (1) IL140085A0 (fr)
NO (1) NO20006149L (fr)
NZ (1) NZ507973A (fr)
WO (1) WO1999064416A2 (fr)
ZA (1) ZA200006697B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
PE20010851A1 (es) * 1999-12-14 2001-08-17 Upjohn Co Esteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
PE20030044A1 (es) 2000-11-17 2003-02-09 Upjohn Co Isoxazolinonas biciclicas de formula i
PE20020689A1 (es) * 2000-11-17 2002-08-03 Upjohn Co Oxazolidinonas con un heterociclo de 6 o 7 miembros unidos con enlace anular al benceno
WO2002064574A2 (fr) * 2001-02-07 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Antibactériens à base de pyridoarylphényle oxazolidinone, compositions et procédés associés
WO2003022824A1 (fr) 2001-09-11 2003-03-20 Astrazeneca Ab Oxazolidinone et/ou isoxazoline utilises comme agents antibacteriens
EP1446403B1 (fr) * 2001-10-25 2006-04-12 AstraZeneca AB Oxazolidinones substituees par un groupe aryle presentant une activite antibacterienne
WO2003035073A1 (fr) 2001-10-25 2003-05-01 Astrazeneca Ab Dérivés d'isoxazoline utilisés en tant qu'agents antimicrobiens
IL163688A0 (en) 2002-02-28 2005-12-18 Astrazeneca Ab 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents
PL372090A1 (en) 2002-02-28 2005-07-11 Astrazeneca Ab Chemical compounds
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
GB0306358D0 (en) 2003-03-20 2003-04-23 Astrazeneca Ab Chemical compounds
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US6969726B2 (en) 2003-06-03 2005-11-29 Rib X Pharmaceuticals Inc Biaryl heterocyclic compounds and methods of making and using the same
JP2007514782A (ja) 2003-12-17 2007-06-07 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法
EP2716647A3 (fr) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Composes Macrocycliques Et Leurs Procedes De Fabrication Et D'utilisation
AP2007003904A0 (en) * 2004-08-06 2007-02-28 Pharmacia & Upjohn Co Llc Oxazolidinones containing oxindoles as antibacterial agents
JP5094398B2 (ja) 2004-09-20 2012-12-12 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環式誘導体およびステアロイル−ＣｏＡデサチュラーゼのメディエータとしてのそれらの使用
CA2580857A1 (fr) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
WO2006034341A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
TW200626138A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
WO2006034440A2 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'agents therapeutiques
WO2006034441A1 (fr) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase
WO2006043121A1 (fr) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Derives d'oxazolidinone servant d'antimicrobiens
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
KR101394307B1 (ko) 2005-06-08 2014-05-13 멜린타 테라퓨틱스, 인크. 트리아졸의 합성 방법
WO2008021338A2 (fr) 2006-08-15 2008-02-21 Wyeth Dérivés d'oxazolidone tricycliques utiles en tant que modulateurs du récepteur de la progestérone
US7649007B2 (en) 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
US7538107B2 (en) 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
WO2008021309A1 (fr) 2006-08-15 2008-02-21 Wyeth Dérivés d'imidazolidin-2-one utiles en tant que modulateurs pr
CN101798302B (zh) 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
CN104364240B (zh) * 2012-06-08 2017-02-22 四川贝力克生物技术有限责任公司 一种用于预防或治疗分支杆菌疾病的药物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329106T2 (de) * 1992-04-30 2001-03-22 Taiho Pharmaceutical Co Ltd Oxazolidinderivat und sein pharmazeutisch verträgliches salz
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
AU668818B2 (en) * 1993-04-07 1996-05-16 Taiho Pharmaceutical Co., Ltd. Thiazolidine derivative and pharmaceutical composition containing the same
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
DK0710657T3 (da) * 1994-11-02 1999-05-25 Merck Patent Gmbh Adhæsionsreceptor-antagonister
CA2227265C (fr) * 1995-08-14 2012-01-03 The Scripps Research Institute Procede et compositions utiles pour inhiber l'angiogenese mediee par .alpha.v.beta.5
ES2165516T3 (es) * 1995-09-01 2002-03-16 Upjohn Co Feniloxazolidinonas con un enlace c-c con anillos heterociclicos de 4-8 miembros.

Also Published As

Publication number Publication date
JP2002517497A (ja) 2002-06-18
WO1999064416A2 (fr) 1999-12-16
IL140085A0 (en) 2002-02-10
EP1082322B1 (fr) 2004-01-28
GB9812019D0 (en) 1998-07-29
HUP0103404A2 (hu) 2002-05-29
CA2332831A1 (fr) 1999-12-16
DE69914478D1 (de) 2004-03-04
NZ507973A (en) 2003-10-31
CN1304410A (zh) 2001-07-18
DE69914478T2 (de) 2004-11-11
HUP0103404A3 (en) 2002-08-28
BR9910915A (pt) 2001-03-06
EP1357122A3 (fr) 2003-12-10
EP1082322A2 (fr) 2001-03-14
WO1999064416A3 (fr) 2000-01-27
AU753865B2 (en) 2002-10-31
KR20010052590A (ko) 2001-06-25
NO20006149D0 (no) 2000-12-04
ATE258552T1 (de) 2004-02-15
AU4156599A (en) 1999-12-30
ZA200006697B (en) 2002-02-18
EP1357122A2 (fr) 2003-10-29

Similar Documents

Publication Publication Date Title
NO20006149L (no) Oksazolidinonderivater, fremgangsmåte for fremstilling derav og farmasöytiske sammensetninger som inneholder dem
BG105001A (en) Oxazolidinone derivatives, process for their preparartion and pharmaceutical compositions containing them
DK0868424T3 (da) 4-Pyrimidinyl- eller 4-pyrazinyl-piperazinyl-phenyloxazolidinonderivater, fremstilling deraf og anvendelse deraf som antibakterielle midler
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
RS49984B (sr) Inhibitori azot (ii) oksid sintaze
DK0418845T3 (da) Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme
DK0528337T3 (da) Thiazolylbenzofuranderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater, der indeholder disse forbin
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ME00440B (fr) Nouvelle forme cristalline $g(b) du sel de tert-butylamine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
IL84917A0 (en) Quinolinone derivative,its preparation and pharmaceutical compositions containing it
MX7189A (es) Derivado de acilo y procedimiento para su preparacion
MX9300433A (es) Compuestos de piridincarboximidamina y composiciones farmaceuticas que los contienen.
WO2003072576A3 (fr) Composes chimiques
AU546887B2 (en) Aroyl amino acids
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
DE69326479D1 (de) Methotrexat-derivate
ES2155655T3 (es) Compuestos de benzotiofeno, usos y formulaciones de los mismos.
DE69030177D1 (de) Sulfamidosulfonylharnstoffderivate und herbizide
DK0532725T3 (da) Isoxazolderivater som lysfilterpræparater
EA200400757A1 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
DK411989D0 (da) 7-(6-amino-2-azabicyclooe2.2.2aaoct-yl)-1,4-dihydro -6-fluor-4-oxo-3-quinolincarboxylsyre-forbindelser, farmaceutiske praeparater indeholdende disse og anvendelse af forbindelserne til fremstilling af antibakterielle laegemidler
ES2102512T3 (es) Inhibidor de la hipertrofia de vasos sanguineos.
CO4770971A1 (es) Compuestos quimicos
AU8292787A (en) Fluorine-containing macrolide compounds and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application